FdaApplication

ANDA 205173

Back to search

Identifiers

Properties

PropertyValue
applicant_nameMYLAN PHARMACEUTICALS INC
application_typeANDA
approval_date2020-01-15

Products (2)

ProductActive ingredientStrengthDosage form
BOSENTANBOSENTAN125MGTABLET;ORAL
BOSENTANBOSENTAN62.5MGTABLET;ORAL

2 products